Thyroxine-induced changes in characteristics and activities of β-adrenergic receptors and adenosine 3’, 5’-monophosphate and guanosine 3’, 5’-monophosphate systems in the heart may be related to reputed catecholamine supersensitivity in hyperthyroidism

Endocrinology

Volumn 107, Issue 1, 1980, Pages 6-16

  Tse, James ^a,b   Wrenn, Robert W ^a   Kuo, J F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; GUANYLYLIMIDODIPHOSPHATE; ISOPRENALINE; PROPRANOLOL; PROTEIN KINASE; RADIOISOTOPE; THYROXINE;

ADENOSINE TRIPHOSPHATE P 32; ANCITABINE H 3; ANIMAL EXPERIMENT; CYCLIC AMP H 3; DIHYDROALPRENOLOL H 3; ENDOCRINE SYSTEM; GUANOSINE 3',5' PHOSPHATE H 3; HEART; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HYPERTHYROIDISM; RAT;

ADENYLATE CYCLASE; ANIMAL; CARDIOMEGALY; CYCLIC AMP; CYCLIC GMP; DIHYDROALPRENOLOL; FLUORIDES; HEART; HYPERTHYROIDISM; ISOPROTERENOL; KINETICS; MALE; MYOCARDIUM; RATS; RECEPTORS, ADRENERGIC; RECEPTORS, ADRENERGIC, BETA; SUPPORT, U.S. GOV'T, P.H.S.; THYROXINE;

EID: 0018879423     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo-107-1-6     Document Type: Article

References (64)

1. Harris TS 1964 Adrenal medullary and thyroid relationships. Physiol Rev 44:161.
2. Waldstein SS 1966 Thyroid-catecholamine interactions. Annu Rev Med 17:123.
3. Grossman W, Robin NI, Johnson LW, Brooks HL, Selenkow HA, Dexter L 1971 The enhanced myocardial contractility of thyrotoxicosis: role of the beta adrenergic receptor. Ann Intern Med 74:869.
4. Grossman W, Robin NI, Johnson LW, Brooks HL, Selenkow HA, Dexter L 1971 Effects of beta blockade on the peripheral manifestations of thyrotoxicosis. Ann Intern Med 74:875.
5. Margolius HS, Gaffney TE 1965 The effects on injected norepinephrine and sympathetic nerve stimulation in hypothyroid and hyperthyroid dogs. J Pharmacol Exp Ther 149:329.
6. van der Schoot JB, Moran NC 1965 An experimental evaluation of the reputed influences of thyroxine on the cardiovascular effects of catecholamines. J Pharmacol Exp Ther 149:336.
7. Cairoli VJ, Crout JR 1967 Role of the autonomic nervous system in the resting tachycardia of experimental hyperthyroidism. J Pharmacol Exp Ther 158:55.
8. Levey GS 1971 Catecholamine sensitivity, thyroid hormone and the heart, a réévaluation. Am J Med 50:413.
9. Kunos G 1977 Thyroid hormone-dependent interconversion of myocardial a- and/8-adrenoceptors in the rat. Br J Pharmacol 59:177.
10. Ciaraldi T, Marinetti GV 1977 Thyroxine and propylthiouracil effects in vivo on alpha and beta adrenergic receptors in rat heart. Biochem Biophys Res Commun 74:984.
11. Williams LT, Lefkowitz RJ, Watanabe AM, Hathaway DR, Besch Jr HR 1977 Thyroid hormone regulation of ^-adrenergic receptor number. J Biol Chem 252:2787.
12. Tsai JS, Chen A 1977 L-Triiodothyronine increases the level of β-adrenergic receptor in cultured myocardial cells. Clin Res 25:303A (Abstract).
13. Kempson S, Marinetti GV, Shaw A 1978 Hormone action at the membrane level. VII. Stimulation of dihydroalprenolol binding to beta-adrenergic receptors in isolated rat heart ventricle slices by triiodothyronine and thyroxine. Biochim Biophys Acta 540:320.
14. Watanabe AM, Hathaway DR, Besch Jr HR, Farmer BB, Harris RA 1977 α-Adrenergic reduction of cyclic adenosine monophosphate concentrations in rat myocardium. Circ Res 40:596.
15. Will-Shahab L, Wollenberger A, Schulze W 1975 Modulation by thyroid hormone of catecholamine binding sites and of adenylate cyclase activity in heart muscle. In: Wollenmann M (ed) Properties of Purified Cholinergic and Adrenergic Receptors. North-Holland, Amsterdam, p 107.
16. Hornbrook KR, Quinn PV, Siegel SH, Brody TM 1965 Thyroid hormone regulation of cardiac glycogen metabolism. Biochem Pharmacol 14:925.
17. McNeill JH, Brody TM 1968 The effect of triiodothyronine pretreatment on ainine-induced cardiac phosphorylase activation. J Pharmacol Exp Ther 161:40.
18. Hornbrook KR, Cabral A 1972 Enhancement by thyroid hormone treatment of norepinephrine-induced phosphorylase activation in the rat heart. Biochem Pharmacol 21:897.
19. Murad F, Chi YM, Rail TW, Sutherland EW 1962 Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3', 5'-phosphate by preparations from cardiac muscle and liver. J Biol Chem 237:1233.
20. George WJ, Poison JB, O’Toole AG, Goldberg ND 1970 Elevation of guanosine 3', 5'-cyclic monophosphate in rat heart after perfusion with acetylcholine. Proc Natl Acad Sci USA 66:398.
21. Kuo JF, Lee TP, Reyes PL, Walton KG, Donnelly Jr TE, Greengard P 1972 Cyclic nucleotide-dependent protein kinases. X. An assay method for the measurement of guanosine 3', 5'-monophosphate in various biological materials and a study of agents regulating its levels in heart and brain. J Biol Chem 247:16.
22. Tse J, Brackett NL, Kuo JF 1978 Alterations in activities of cyclic nucleotide systems and in β-adrenergic receptor-mediated activation of cyclic AMP-dependent protein kinase during progression and regression of isoproterenol-induced cardiac hypertrophy. Biochim Biophys Acta 542:299.
23. Tse J, Powell JR, Baste CA, Priest RE, Kuo JF 1979 Isoproterenol-induced cardiac hypertrophy: modifications in characteristics of β-adrenergic receptor, adenylate cyclase and ventricular contraction. Endocrinology 105:246.
24. Hermann J, Rusche HJ, Kruskemper HL 1974 Rapid radioimmunoassay for the evaluation of thyroxine in unextracted serum. Clin Chim Acta 54:69.
25. Kuo JF, Greengard P 1972 An assay method of cyclic AMP and cyclic GMP based upon their ability to activate cyclic AMP-dependent and cyclic GMP-dependent protein kinases. Adv Cyclic Nucleotide Res 2:40.
26. Narayanan N, Sulake PV 1977 5'-Guanylylimidodiphosphate-acti-vated adenylate cyclase of cardiac sarcolemma displays higher affinity for magnesium ions. Mol Pharmacol 13:1033.
27. Kuo JF 1974 Guanosine 3':5'-monophosphate-dependent protein kinase in mammalian tissues. Proc Natl Acad Sci USA 71:4037.
28. Shoji M, Patrick JG, Davis CW, Kuo JF 1977 Guanosine cyclic monophosphate-dependent protein kinase from foetal calf heart: purification, general properties and catalytic subunit. Biochem J 161:213.
29. Kuo WN, Kuo JF 1976 Isolation of stimulatory modulator of guanosine 3':5'-monophosphate-dependent protein kinase from mammalian heart devoid of inhibitory modulator of adenosine 3': 5'-monophosphate-dependent protein kinase. J Biol Chem 251:4283.
30. Kuo WN, Shoji, Kuo JF 1976 Stimulatory modulator of guanosine 3':5'-monophosphate-dependent protein kinase from mammalian tissue. Biochim Biophys Acta 437:142.
31. Walsh DA, Ashby CD, Gonzalez C, Calkins D, Fisher EH, Krebs EG 1971 Purification and characterization of a protein inhibitor of adenosine 3', 5'-monophosphate-dependent protein kinases. J Biol Chem 246:1977.
32. Kuo JF, Kuo WN, Shoji M, Davis CW, Seery VL, Donnelly Jr TE 1976 Purification and general properties of guanosine 3':5'-mono-phosphate-dependent protein kinase from guinea pig fetal lung. J Biol Chem 251:1759.
33. Kuo JF, Greengard P 1969 Cyclic nucleotide-dependent protein kinases. IV. Widespread occurrence of adenosine 3', 5'-monophos-phate-dependent protein kinase in various tissues and phyla of the animal kingdom. Proc Natl Acad Sci USA 64:1349.
34. Strehler BL, McElroy WD 1957 Assay of adenosine triphosphate. Methods Enzymol 3:871.
35. Stanley PE, Williams SG 1969 Use of the liquid scintillation spectrometer for determining adenosine triphosphate by the luciferase enzyme. Anal Biochem 29:381.
36. Thompson WJ, Appleman MM 1971 Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 10:311.
37. Davis CW, Kuo JF 1977 Purification and characterization of guanosine 3':5'-monophosphate-specific phosphodiesterase from guinea pig lung. J Biol Chem 252:4078.
38. Kuo JF, Brackett NL, Shoji M, Tse J 1978 Cytidine 3':5'-mono-phosphate phosphodiesterase in mammalian tissues: Occurrence and biological involvement. J Biol Chem 253:2518.
39. Feigen GA, Masuoka DT, Thienes CH, Sauders PR, Sutherland GB 1952 Mechanical response of the isolated electrically driven rat ventricular strip. I. Preparation and standardization. Stanford Med Bull 10:27.
40. Chenoweth MB, Koelle ES 1946 An isolated heart perfusion system adapted to the determination of nongaseous metabolites. J Lab Clin Med 31:600.
41. Goldstein A, Aronow L, Kalman SM 1974 Principles of Drug Action: The Basis of Pharmacology, ed 2. John Wiley and Sons, New York, p. 379.
42. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265.
43. Frazer A, Hess ME, Shanfeld J 1969 The effects of thyroxine on rat heart adenosine 3', 5'-monophosphate, phosphorylase b kinase and phosphorylase a activity. J Pharmacol Exp Ther 170:10.
44. McNeill JH, Muschek LD, Brody TM 1969 The effect of triodo-thyronine on cyclic AMP, phosphorylase, and adenyl cyclase in rat heart. Can J Physiol Pharmacol 47:913.
45. Lefkowitz RJ, Mullikin D, Caron MG 1976 Regulation of α-adie-nergic receptors by guanyl-5'-yl imidodiphosphate and other purine nucleotides. J Biol Chem 251:4686.
46. Ross EM, Maguire ME, Sturgill TW, Biltonen RL, Gilman AG 1977 The relationship between the β-adrenergic receptor and adenylate cyclase: Studies of ligand binding and enzyme activity in purified membranes of S49 lymphoma cells. J Biol Chem 252:5761.
47. Keely SL, Corbin JD, Park CR 1975 Regulation of adenosine 3':5'-monophosphate-dependent protein kinase. J Biol Chem 250:4832.
48. Cheng YC, Bloch A 1978 Demonstration, in leukemia L-1210 cells of a phosphodiesterase activity on 3':5'-cyclic CMP but not on 3':5'-cyclic AMP or 3':5'-cyclic GMP. J Biol Chem 253:2522.
49. Shoji M, Brackett NL, Kuo JF 1978 Cytidine 3':5'-monophosphate (cyclic CMP) phosphodiesterase: decreased activity in the regenerating and developing liver. Science 202:826.
50. Shoji M, Brackett NL, Helfman DM, Morris HP, Kuo JF 1978 Decreased activity of cytidine 3':5'-monophosphate (cyclic CMP) phosphodiesterase in the fast-growing Morris hepatome 3924A but not in the slow-growing Morris hepatome 9618A. Biochem Biophys Res Commun 83:1140.
51. Helfman DM, Brackett NL, Kuo JF 1978 Depression of cytidine 3': 5'-monophosphate (cyclic CMP) phosphodiesterase activity in developing tissues of guinea pigs. Proc Natl Acad Sei USA 75:4422.
52. Cohen J, Aroesty JM, Rosenfeld MG 1966 Determinants of thyroxine-induced cardiac hypertrophy in mice. Circ Res 18:388.
53. Kuo JF, Davis CW, Tse J 1976 Depressed cardiac cyclic GMP-dependent protein kinase in spontaneously hypertensive rats and its further depression by guanethidine. Nature 261:335.
54. Goldberg ND, Haddox MK, Nichol SE, Glass DB, Sanford CH, Kuehl Jr FA, Estensen R 1975 Biological regulation through opposing influences of cyclic GMP and cyclic AMP: the yin-yang hypothesis. Adv Cyclic Nucleotide Res 5:307.
55. Holland WC, Klein RL 1960 Chemistry of the failing heart. In: Kugelmass IN (ed) Chemistry of Heart Failure. Charles C Thomas, Springfield IL, p 76.
56. Saks VA, Rosenshtraukh LV, Undrovinas AI, Smirnov VN, Chazov El 1976 Studies of energy transport in heart cells. Intracellular creatine contents as a regulatory factor of frog heart energetics and force of contraction. Biochem Med 16:21.
57. McNeill JH 1978 Thyroid hormone-induced supersensitivity to the cardiac phosphorylase-activating effect of adrenergic amines. Cardiac Metab 11:413.
58. Moran NC, van der Schoot JB 1967 Thyroid-catecholamine interactions. In: Tanz RD, Kavaler F, Roberts J (eds) Factors Influencing Myocardial Contractility. Academic Press, New York, p 603.
59. Sharma VK, Banerjee SP 1977 Muscarinic cholinergic receptors in rat heart. Effects of thyroidectomy. J Biol Chem 252:7444.
60. Trendelenburg U 1953 Thyroid and hyperglycemia produced by adrenaline and noradrenaline. Br J Pharmacol 8:454.
61. Brewster WR, Issac JP, Osgood PF, King TL 1956 The hemodynamic and metabolic interrelationships in the activity of epinephrine, norepinephrine and the thyroid hormone. Circulation 13:1.
62. Lee ES 1942 The effect of thyroxine on the sensitivity of the nictitating membrane of the cat. Am J Physiol 135:452.
63. Hoffmann F, Middleton S, Talensnik J 1947 Influence of the thryoid hormone on the effector systems of the mammalian heart. Am J Physiol 148:689.
64. Frazer A, Hess ME 1969 Parasympathetic responses in hyperthyroid rats. J Pharmacol Exp Ther 170:1.